中华健康管理学杂志
中華健康管理學雜誌
중화건강관이학잡지
CHINESE JOURNAL OF HEALTH MANAGEMENT
2012年
2期
89-91
,共3页
类风湿关节炎%骨质疏松%健康管理%骨密度%骨折
類風濕關節炎%骨質疏鬆%健康管理%骨密度%骨摺
류풍습관절염%골질소송%건강관리%골밀도%골절
Rheumatoid arthritis%Osteoporosis%Health management%Bone mineral density%Fracture
目的 探讨健康管理在类风湿关节炎合并骨质疏松症治疗中的作用.方法 绝经后类风湿关节炎合并骨质疏松症的妇女140例经知情同意为观察对象,随机分为类风湿关节炎合并骨质疏松药物治疗组(A组)与类风湿关节炎、骨质疏松药物治疗并予健康管理干预组(B组),进行12个月的随机对照研究,分别于入组基线时与12个月结束时测量前臂、腰椎及髋部的骨密度,并计算12个月内两组患者的骨折发生率.结果 经过12个月治疗后,比较两组患者治疗前后三部位骨密度变化的差值均具有明显的差异,B组(0.54 ±0.14,0.80±0.12,0.73±0.15)大于A组(0.50±0.13,0.78±0.15,0.68±0.14),差异具有统计学意义(P＜0.05).B组患者的骨密度升高幅度与依从性均明显高于A组(P＜0.05),且其骨折发生率明显低于A组.结论 类风湿关节炎合并骨质疏松症患者的治疗过程中,健康管理在增强患者依从性的同时,明显提高药物治疗效果,是治疗有效性与持续性的有力保障.
目的 探討健康管理在類風濕關節炎閤併骨質疏鬆癥治療中的作用.方法 絕經後類風濕關節炎閤併骨質疏鬆癥的婦女140例經知情同意為觀察對象,隨機分為類風濕關節炎閤併骨質疏鬆藥物治療組(A組)與類風濕關節炎、骨質疏鬆藥物治療併予健康管理榦預組(B組),進行12箇月的隨機對照研究,分彆于入組基線時與12箇月結束時測量前臂、腰椎及髖部的骨密度,併計算12箇月內兩組患者的骨摺髮生率.結果 經過12箇月治療後,比較兩組患者治療前後三部位骨密度變化的差值均具有明顯的差異,B組(0.54 ±0.14,0.80±0.12,0.73±0.15)大于A組(0.50±0.13,0.78±0.15,0.68±0.14),差異具有統計學意義(P＜0.05).B組患者的骨密度升高幅度與依從性均明顯高于A組(P＜0.05),且其骨摺髮生率明顯低于A組.結論 類風濕關節炎閤併骨質疏鬆癥患者的治療過程中,健康管理在增彊患者依從性的同時,明顯提高藥物治療效果,是治療有效性與持續性的有力保障.
목적 탐토건강관리재류풍습관절염합병골질소송증치료중적작용.방법 절경후류풍습관절염합병골질소송증적부녀140례경지정동의위관찰대상,수궤분위류풍습관절염합병골질소송약물치료조(A조)여류풍습관절염、골질소송약물치료병여건강관리간예조(B조),진행12개월적수궤대조연구,분별우입조기선시여12개월결속시측량전비、요추급관부적골밀도,병계산12개월내량조환자적골절발생솔.결과 경과12개월치료후,비교량조환자치료전후삼부위골밀도변화적차치균구유명현적차이,B조(0.54 ±0.14,0.80±0.12,0.73±0.15)대우A조(0.50±0.13,0.78±0.15,0.68±0.14),차이구유통계학의의(P＜0.05).B조환자적골밀도승고폭도여의종성균명현고우A조(P＜0.05),차기골절발생솔명현저우A조.결론 류풍습관절염합병골질소송증환자적치료과정중,건강관리재증강환자의종성적동시,명현제고약물치료효과,시치료유효성여지속성적유력보장.
Objective To explore the role of health management in the treatment of rheumatoid arthritis combined with osteoporosis.Methods A total of 140 women with postmenopausal osteoporosis and rheumatoid arthritis were enrolled in this 12-month randomized controlled study and randomly assigned to receive drug therapy ( group A,n =70 ) or drug therapy + health management ( group B,n =70 ).Bone mineral density (BMD) of the forearm,lumbar spine and hip was measured by using dual-X-ray absorptiometry at baseline and 12 months after the intervention.The rates of fractures were calculated at 12months.Results BMD of the forearm,lumbar spine and hip of both groups were significantly increased at 12 months (group A:0.50 ± 0.13,0.78 ± 0.15 and 0.68 ± 0.14,respectively,all P ＜ 0.05; group B:0.54± 0.14,0.80 ± 0.12 and 0.73 ± 0.15,respectively,all P ＜ 0.05 ).The elevation of BMD and therapy compliance of group B were significantly higher than those of group A ( P ＜ 0.05 ),while the rate of fracture was relatively lower.Conclusions Health management can significantly improve patient compliance and medication efficacy.
